Jiangsu Nanfang Medical
Jiangsu Nanfang Medical Co., Ltd. engages in the research and development, production, and sale of transdermal, medical proof fabrics, adhesive tapes and bandages, sports protection, first-aid kits, and care products in China and internationally. It offers medical wound dressings, capsicum plasters, physical therapy tapes, pain relief sleeves, rigid sports tapes, wound plaster dressings, medical … Read more
Jiangsu Nanfang Medical (603880) - Total Assets
Latest total assets as of September 2025: CN¥993.46 Million CNY
Based on the latest financial reports, Jiangsu Nanfang Medical (603880) holds total assets worth CN¥993.46 Million CNY as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Jiangsu Nanfang Medical - Total Assets Trend (2012–2024)
This chart illustrates how Jiangsu Nanfang Medical’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Jiangsu Nanfang Medical - Asset Composition Analysis
Current Asset Composition (December 2024)
Jiangsu Nanfang Medical's total assets of CN¥993.46 Million consist of 37.9% current assets and 62.1% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 4.7% |
| Accounts Receivable | CN¥130.39 Million | 12.3% |
| Inventory | CN¥188.90 Million | 17.9% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥42.33 Million | 4.0% |
| Goodwill | CN¥0.00 | 0.0% |
Asset Composition Trend (2012–2024)
This chart illustrates how Jiangsu Nanfang Medical's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Jiangsu Nanfang Medical's current assets represent 37.9% of total assets in 2024, a decrease from 76.9% in 2012.
- Cash Position: Cash and equivalents constituted 4.7% of total assets in 2024, down from 20.8% in 2012.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 4.0% of total assets, an increase from 2.0% in 2012.
- Asset Diversification: The largest asset category is inventory at 17.9% of total assets.
Jiangsu Nanfang Medical Competitors by Total Assets
Key competitors of Jiangsu Nanfang Medical based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Beijing Centergate Technologies Holding Co Ltd
SHE:000931
|
China | CN¥3.82 Billion |
|
Blue Sail Medical Co Ltd
SHE:002382
|
China | CN¥16.46 Billion |
|
Andon Health Co Ltd
SHE:002432
|
China | CN¥28.98 Billion |
|
Allmed Medical Products Co Ltd Class A
SHE:002950
|
China | CN¥5.35 Billion |
|
Inix Technologies Holdings Bhd
KLSE:0094
|
Malaysia | RM72.53 Million |
|
Focus Point Holdings Bhd
KLSE:0157
|
Malaysia | RM328.19 Million |
|
Careplus Group Bhd
KLSE:0163
|
Malaysia | RM286.61 Million |
|
LKL International Bhd
KLSE:0182
|
Malaysia | RM173.46 Million |
Jiangsu Nanfang Medical - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Jiangsu Nanfang Medical generates 0.57x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Jiangsu Nanfang Medical is currently not profitable relative to its asset base.
Jiangsu Nanfang Medical - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.52 | 0.77 | 1.79 |
| Quick Ratio | 0.26 | 0.37 | 1.46 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥-343.68 Million | CN¥ -163.77 Million | CN¥ 284.76 Million |
Jiangsu Nanfang Medical - Advanced Valuation Insights
This section examines the relationship between Jiangsu Nanfang Medical's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 7.19 |
| Latest Market Cap to Assets Ratio | 0.13 |
| Asset Growth Rate (YoY) | -17.3% |
| Total Assets | CN¥1.06 Billion |
| Market Capitalization | $137.76 Million USD |
Valuation Analysis
Below Book Valuation: The market values Jiangsu Nanfang Medical's assets below their book value (0.13 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Jiangsu Nanfang Medical's assets decreased by 17.3% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Jiangsu Nanfang Medical (2012–2024)
The table below shows the annual total assets of Jiangsu Nanfang Medical from 2012 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥1.06 Billion | -17.28% |
| 2023-12-31 | CN¥1.28 Billion | -12.35% |
| 2022-12-31 | CN¥1.46 Billion | +17.98% |
| 2021-12-31 | CN¥1.24 Billion | +15.15% |
| 2020-12-31 | CN¥1.07 Billion | +23.35% |
| 2019-12-31 | CN¥869.60 Million | +2.81% |
| 2018-12-31 | CN¥845.81 Million | +2.78% |
| 2017-12-31 | CN¥822.96 Million | +59.32% |
| 2016-12-31 | CN¥516.55 Million | +9.12% |
| 2015-12-31 | CN¥473.37 Million | +8.32% |
| 2014-12-31 | CN¥437.01 Million | +17.05% |
| 2013-12-31 | CN¥373.35 Million | -1.70% |
| 2012-12-31 | CN¥379.79 Million | -- |